BioCentury
ARTICLE | Clinical News

Tretinoin gel: Completed Phase II enrollment

May 5, 2014 7:00 AM UTC

Phosphagenics completed enrollment of 54 patients in an Australian and New Zealand Phase II trial comparing its tretinoin gel once daily for 3 months vs. placebo or Retin-A Micro tretinoin gel micros...